Loading CI detail
Loading ticker data...
Loading CI detail
The Cigna Group provides insurance and related products and services in the United States.
Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges.
The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Chart data unavailable
Flagship Harbor Advisors LLC raised its holdings in shares of Cigna Group (NYSE: CI) by 45.5% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,990 shares of the health services provider's stock after acquiring an additional 1,872 shares during
Cigna Group remains a Buy, with catalysts for double-digit adjusted income per share growth resuming in 2027 and beyond. CI's pharmacy segment, biosimilar adoption, behavioral health expansion, and aggressive share buybacks drive both topline and margin growth. Shares trade at an 8.5x forward P/E, a 29% discount to fair value, supporting a projected 17% annual total return through 2031.
Banque Pictet and Cie SA increased its position in shares of Cigna Group (NYSE: CI) by 40.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 25,216 shares of the health services provider's stock after purchasing an additional 7,204 shares during
Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
BLOOMFIELD, Conn., April 2, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its first quarter 2026 financial results on Thursday, April 30, 2026, and will host a conference call the same day.
Exchange Traded Concepts LLC boosted its holdings in Cigna Group (NYSE: CI) by 31.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,539 shares of the health services provider's stock after buying an additional 2,055 shares during
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
apricus wealth LLC lifted its stake in shares of Cigna Group (NYSE: CI) by 715.9% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,505 shares of the health services provider's stock after buying an additional 8,340 shares during the period. apricus wealth
UBS analysts have outlined a set of high-conviction healthcare ideas where they believed the market was underappreciating earnings durability and the scale of upcoming catalysts, focusing on stocks backed by differentiated views and proprietary insights. In biotechnology, they identified Cogent Biosciences (NASDAQ:COGT) as their top pick, arguing the company offered scarcity value as a SMID-cap advancing two late-stage, potentially blockbuster assets.
Pallas Capital Advisors LLC raised its position in Cigna Group (NYSE: CI) by 133.1% during the undefined quarter, according to its most recent filing with the SEC. The institutional investor owned 4,774 shares of the health services provider's stock after acquiring an additional 2,726 shares during the period. Pallas Capital Advisors LLC's holdings
With grant funding, more than 20 nonprofit partners expanded access to stable housing and wraparound support services to support veteran communities in 10 states. Read the new Impact Report with outcomes in Arizona, Connecticut, Florida, Georgia, Illinois, Missouri, New Jersey, Pennsylvania, Tennessee and Texas.
CIBC Bancorp USA Inc. purchased a new stake in Cigna Group (NYSE: CI) in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 36,834 shares of the health services provider's stock, valued at approximately $10,617,000. Several other large investors have also modified their
Danske Bank A S bought a new position in Cigna Group (NYSE: CI) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 179,920 shares of the health services provider's stock, valued at approximately $51,862,000. Danske Bank A S owned approximately
Banco Bilbao Vizcaya Argentaria S.A. lifted its position in shares of Cigna Group (NYSE: CI) by 13.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 34,114 shares of the health services provider's stock after purchasing an additional 4,066 shares
California Public Employees Retirement System trimmed its position in Cigna Group (NYSE: CI) by 9.0% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 690,200 shares of the health services provider's stock after selling 67,990 shares during the quarter. California Public
